MorphoSys AG: MorphoSys Reports Preliminary 2023 Monjuvi U S Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
MorphoSys AG / Key word(s): Capital IncreaseAd hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process13-Dec-2023 / 22:01 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The.
EQS-Adhoc: Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102 7 million finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
EQS-Ad-hoc: MorphoSys AG / Key word: Capital Increase
Ad hoc: MorphoSys AG Places New Shares From Cash Capital Increase with Gross Proceeds Of Approximately EUR 102.7 million
14-Dec-2023 /.
EQS-News: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102 7 Million finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.